For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has ...

The development of the human brain, with its extraordinary range of cognitive abilities, is an awe-inspiring feat of evolution. Each of its tens of billions of cells must be born at precisely the ...

Abstract: The increasing integration of converter-interfaced renewable energy sources (CI-RES) in distribution networks (DNs), combined with the gradual decommissioning of synchronous generators (SGs) ...

Abstract: A historical review of E-Model development for time-dependent dielectric breakdown (TDDB) is presented. The E-Model tends to be a very useful reliability assurance model for TDDB because of ...